Please assess the completion status of the following clinical trial:

Trial Title: Aripiprazole Treatment of the Prodrome

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* You are between the ages of 13 and 22.~* You are English-speaking.~* You have a diagnosed psychotic disorder, including: schizophrenia, schizophreniform disorder, schizoaffective disorder, or other psychotic disorder~* OR -~* You are experiencing one or more pre-psychotic symptoms like unusual thoughts, suspiciousness, or unusual perceptual experiences.~* You meet additional RAP criteria assessed during screening and interview.~Exclusion Criteria:~* You have a diagnosis of bipolar disorder or major depression with psychotic features.~* You have a history of neurological, neuroendocrine, or other medical conditions known to affect the brain.~* You have past or current substance dependence.~* You are currently taking Aripiprazole.~* You have taken Aripiprazole in the past.~* You are currently taking and responding well to another medication.

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 22 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).